Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.62M Sell
15,783
-9,042
-36% -$1.02M 0.16% 122
2025
Q4
$3.11M Sell
24,825
-7,214
-23% -$919K 0.3% 62
2025
Q3
$4.29M Sell
32,039
-5,824
-15% -$765K 0.44% 45
2025
Q2
$5.15M Sell
37,863
-211
-0.6% -$27.8K 0.56% 39
2025
Q1
$5.05M Sell
38,074
-2,041
-5% -$260K 0.58% 32
2024
Q4
$4.54M Sell
40,115
-2,081
-5% -$240K 0.51% 39
2024
Q3
$4.81M Buy
42,196
+19,024
+82% +$2.09M 0.57% 37
2024
Q2
$2.41M Sell
23,172
-6,363
-22% -$675K 0.49% 48
2024
Q1
$3.36M Buy
29,535
+9,111
+45% +$1.04M 0.68% 35
2023
Q4
$2.25M Sell
20,424
-3,053
-13% -$305K 0.39% 25
2023
Q3
$2.27M Buy
+23,477
New +$2.47M 0.75% 24

Other funds holding ABT

Norden Group's ABT Position: Q1 2026 in Review

Norden Group reduced its Abbott (ABT) stake by 36% in Q1 2026, selling an estimated $1.02M and leaving 15,783 shares worth $1.62M. The position accounts for 0.16% of the portfolio, ranked #122.

Norden Group first reported a position in ABT in Q3 2023 and has held it in 11 quarters since. The position peaked at $5.15M in Q2 2025. 3,087 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Norden Group held 15,783 shares of Abbott worth $1.62M as of Q1 2026.
  • Norden Group sold 9,042 Abbott shares in Q1 2026, an estimated $1.02M.
  • Abbott made up 0.16% of Norden Group's portfolio in Q1 2026, its #122 holding.
  • Norden Group first reported a position in Abbott in Q3 2023 and has held it in 11 quarters since.
  • Norden Group's Abbott position peaked at $5.15M in Q2 2025.
  • 3,087 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.